Article
Impact of APOE Genotype on Neurocognition Following Conformal Whole Brain Radiotherapy for Brain Metastases: A Post hoc Analysis of Phase II Randomized Trial
2025-05-19
Abstract excerpt
<title>Abstract</title> <p> <bold>Background</bold> The genetic risk of radiotherapy-induced cognitive decline (RICD) in patients undergoing whole-brain radiotherapy (WBRT) has not been clearly established. Apolipoprotein E (APOE) polymorphisms, known to influence cognitive aging and Alzheimer’s disease risk, may also modulate neurocognitive outcomes after cranial irradiation. This post-hoc analysis investigate...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b4a91642-a04f-5e23-bcf8-b95b59b88ecc
- DOI
- 10.21203/rs.3.rs-6431871/v1
